Vsee Health, Inc. (VSEE)

Market price: $1.92

6 methods not shown

• EV / EBITDA: EBITDA is non-positive — an EBITDA multiple yields no meaningful enterprise value (loss-making at the EBITDA line)
• EV / Revenue: the market prices this company far outside its sector's EV / Revenue range (its own multiple is 9.65 vs a sector band of 1.01–2.06) — a sector-average bar would be misleading here, so it is withheld
• EV / Gross Profit: the market prices this company far outside its sector's EV / Gross Profit range (its own multiple is 22.62 vs a sector band of 1.42–3.91) — a sector-average bar would be misleading here, so it is withheld
• P / E: diluted EPS is non-positive — P/E is not meaningful for a loss-making period
• P / B: the market prices this company far outside its sector's P / B range (its own multiple is 14.33 vs a sector band of 2.41–4.48) — a sector-average bar would be misleading here, so it is withheld
• DCF (FCFF): base unlevered FCF is non-positive (-8,851,515.26) — nothing to discount; a standard FCFF DCF does not apply

Pre-profit company — earnings-based methods not meaningful.

We can't value this company — not enough of the financial data our methods require is available from its SEC filings.